All Times EDT
Clinical development is lengthy and expensive. Many steps can be taken to render clinical development faster, better, and more cost-effectively. Some steps are wholly within the purview of the sponsor, some within FDA, and some that require collaboration among all stakeholders. Areas of opportunity include CID (Complex Innovative Design), PFDD (Patient Focused Drug Development), and RWE (Real World Evidence) among others. This presentation will explore the role of leadership in putting innovation into practice and bringing about a meaningful and measurable impact on clinical development.